These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8665626)

  • 1. [The practice of drug monitoring in the Lorraine Regional Center of Drug Monitoring (CRPV)].
    Trechot P
    Bull Soc Sci Med Grand Duche Luxemb; 1995; 132(3):41-2. PubMed ID: 8665626
    [No Abstract]   [Full Text] [Related]  

  • 2. [The safety of pharmacotherapy in the light of monitoring adverse drug reaction].
    Jabłecka A; Korzeniowska K
    Przegl Lek; 2010; 67(10):1091-2. PubMed ID: 21360968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of reports on "pregnancy and drugs" received during a period of 39 months by the Regional Pharmacovigilance Center, Lorraine (Nancy)].
    Hanesse B; Trechot P; el Kouch S; Pierfitte C; Royer R; Netter P
    Therapie; 1995; 50(5):471-2. PubMed ID: 8571291
    [No Abstract]   [Full Text] [Related]  

  • 4. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active drug monitoring of adverse drug reactions in pediatric emergency department].
    Planchamp F; Nguyen KA; Vial T; Nasri S; Javouhey E; Gillet Y; Ranchin B; Villard F; Floret D; Cochat P; Gueyffier F; Kassaï B;
    Arch Pediatr; 2009 Feb; 16(2):106-11. PubMed ID: 19117738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Joint program of pharmacovigilance in Quebec: comparison with France, Aquitaine and the Basque region].
    Biron P; Balency D
    Therapie; 1996; 51(5):578-81. PubMed ID: 9138400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japan plans improved monitoring of new drugs.
    Lamar J
    BMJ; 2000 Jun; 320(7249):1560. PubMed ID: 10845957
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry.
    Mayans MV; Robertson SE; Duclos P
    Bull World Health Organ; 2000; 78(9):1167. PubMed ID: 11019467
    [No Abstract]   [Full Text] [Related]  

  • 9. The Welsh Adverse Drug Reactions Scheme: experience of a UK regional monitoring centre.
    Houghton JE; Pinto Pereira LM; Woods FJ; Richens A; Routledge PA
    Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):93-107. PubMed ID: 8836315
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.
    Stelfox HT; Ahmed SB; Fiskio J; Bates DW
    Clin Pharmacol Ther; 2004 Jan; 75(1):110-22. PubMed ID: 14749697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reaction monitoring in pediatric practice.
    Kshirsagar NA; Karande S
    Indian Pediatr; 1996 Dec; 33(12):993-8. PubMed ID: 9141798
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tendinopathies and fluoroquinolones: a public health problem? Value of drug monitoring studies].
    Pierfitte C
    Bull Soc Sci Med Grand Duche Luxemb; 1995; 132(3):39-40. PubMed ID: 8665625
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reaction reporting and monitoring: role of practising physicians.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 2000 Aug; 48(8):852. PubMed ID: 11273490
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety monitoring of new anti-malarials in immediate post-marketing phase.
    Edwards IR
    Med Trop (Mars); 1998; 58(3 Suppl):93-6. PubMed ID: 10212911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A 30-month study of the calls to the Regional Drug Monitoring Center in Lorraine (Nancy)].
    Trechot PF; Royer RJ; Gaire M; Gaspard MC; Netter P
    Therapie; 1990; 45(1):43-6. PubMed ID: 2343435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can the screening of blood samples identify adverse drug reactions?].
    Buajordet I; Laake K; Brørs O
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1637-9. PubMed ID: 17571101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug eruption: assessment of causality].
    Bachot N; Roujeau J
    Ann Dermatol Venereol; 2000 May; 127(5):542-5. PubMed ID: 10863192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.